|
EP2656857A1
|
|
Oral liquid formulation
|
|
EP2384742A1
|
|
Pharmaceutical excipient, method for its preparation and use thereof
|
|
EP2042166A1
|
|
Nanocapsules for oral delivery of proteins
|
|
EP2016946A1
|
|
Chitosan silicon dioxide coprecipitate composition for use as a therapeutically active agent
|
|
EP2000132A1
|
|
Solid pharmaceutical formulation
|
|
EP1997480A1
|
|
Mineral-fiber solid dispersion, method for preparing the same and use thereof as pharmaceutical tableting aid
|
|
EP1974751A1
|
|
Formulations for non-steroidal anti-inflammatory drugs
|
|
EP1955711A1
|
|
Composition comprising covalent conjugates of chitosan and an acidic drug for parenteral administration
|
|
EP1955693A1
|
|
Composition comprising chitosan and an acidic drug for oral controlled release
|
|
EP1955710A1
|
|
Aqueous composition comprising chitosan and an acidic drug
|
|
EP1952816A1
|
|
Multi-component herbal composition for the treatment of male erectile dysfunction
|
|
EP1946750A1
|
|
Co-precipitate, method for preparing the same and uses thereof
|
|
EP1947458A1
|
|
Using colour conjugated chitosan and chitosan oligo-saccharides in the manufacture of a lateral-flow test device
|
|
JO2618B1
|
|
Device for rapid immuno-chromatographic HIV testing & uses thereof
|
|
EP1886671A1
|
|
Starch silica co-precipitate, method for preparing the same and use thereof
|
|
EP1886667A1
|
|
Microemulsified drug formulation
|
|
JO2568B1
|
|
Novel Pharmaceutical Chitosan for use in Solid Dosage Forms
|
|
EP1882939A1
|
|
Urinary immunochromatographic antigen detection cup
|
|
EP1882940A1
|
|
Chitosan as a colour-fixing agent
|
|
EP1882943A1
|
|
Saliva immunochromatographic detection cup
|
